| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/07/2002 | EP1228373A2 Diagnosis and therapy of cancer using sgp28-related molecules |
| 08/07/2002 | EP1228237A1 Expression vectors, transfection systems, and method of use thereof |
| 08/07/2002 | EP1228236A2 Compositions for transfecting nucleic acids and their use |
| 08/07/2002 | EP1228235A1 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 08/07/2002 | EP1228234A2 Production of chimeric capsid vectors |
| 08/07/2002 | EP1228232A2 Recombinant sendai virus vector for introducing exogenous genes to airway epithelia |
| 08/07/2002 | EP1228222A2 Human transferase molecules |
| 08/07/2002 | EP1228217A2 Conserved neisserial antigens |
| 08/07/2002 | EP1228210A2 Nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 08/07/2002 | EP1228209A1 "insulin-responsive sequence dna binding protein-1" (irsdbp-1), gene encoding it and uses thereof |
| 08/07/2002 | EP1228208A2 36p6d5: secreted tumor antigen |
| 08/07/2002 | EP1228202A2 Antisense compositions and cancer-treatment methods |
| 08/07/2002 | EP1228199A2 Method for directed packaging of molecular substances in protein shells |
| 08/07/2002 | EP1228193A2 Feline calicivirus genes and vaccines, in particular recombined vaccines |
| 08/07/2002 | EP1228095A1 Modified gp100 and uses thereof |
| 08/07/2002 | EP1228092A1 24 human secreted proteins |
| 08/07/2002 | EP1228091A1 Choline transporter like (ctl) membrane proteins involved in choline transport |
| 08/07/2002 | EP1228085A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 08/07/2002 | EP1227840A1 Adjuvanted genetic vaccines |
| 08/07/2002 | EP1227838A2 Melanoma vaccine and methods of making and using same |
| 08/07/2002 | EP1227837A1 Method of inducing and/or enhancing an immune response to tumor antigens |
| 08/07/2002 | EP1227833A1 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 08/07/2002 | EP1227830A1 Method of inducing angiogenesis |
| 08/07/2002 | EP1227825A1 Isolation and expansion of human marrow stromal cells |
| 08/07/2002 | EP1181352A4 Versican and epithelial-mesenchymal interaction |
| 08/07/2002 | EP1156789A4 Therapy for human cancers using cisplatin and other drugs or genes encapsulated into liposomes |
| 08/07/2002 | EP0972015A4 Enzyme having s-adenosyl-l-homocysteine hydrolase (ahcy) type activity |
| 08/07/2002 | EP0809517B1 Anti-transforming growth factor-beta gene therapy |
| 08/07/2002 | CN1362968A Novel peptides |
| 08/07/2002 | CN1362965A cytoplasmic transfer to de-differentiate recipient cells |
| 08/07/2002 | CN1362885A AIDS virus vaccine with use of sendai virus vector |
| 08/07/2002 | CN1088599C Therapeutic compositions comprising antigen or an in vivo generator comprising amino-acid serial compounds |
| 08/06/2002 | US6429303 Nucleic acids encoding members of the human B lymphocyte activation antigen B7 family and methods of using the same |
| 08/06/2002 | US6429290 Modulation of body weight; diagnosis; dietetics; gene expression; drug screening |
| 08/06/2002 | US6429201 Method for immunization against hepatitis B |
| 08/06/2002 | US6429200 Negatively-charged, zwitterionic, or neutral complex for delivery to cell formed by inserting a nucleic acid into a negatively-charged, zwitterionic, or neutral reverse micelle wherein the nucleic acid is compacted |
| 08/06/2002 | US6429009 Recombinant retroviral expression vector comprising a replication-defective, nonproducing, interfering, modified human immunodeficiency virus type 1 (hiv-1) f12 proviral genome |
| 08/06/2002 | US6428988 (aav); first cre recombinase vector, second vector contains a promoter, spacer sequence flanked by loxp sites and rep/cap, and third vector containing a transgene and regulatory sequences flanked by aav inverted terminal repeats (itr) |
| 08/06/2002 | US6428977 Transforming growth factor-beta (tgf-beta); nucleic acid; polypeptide promotes the formation of ventral mesoderm in xenopus animal pole explants; use promoting osteogenesis for example |
| 08/06/2002 | US6428970 Chemokine inhibition of immunodeficiency virus |
| 08/06/2002 | US6428953 Retrovirus vectors; plasmids; gene delivery; genetic engineering; human immunodeficiency virus |
| 08/06/2002 | US6428951 Comprising reassembly of separate fragments of monomeric enzyme wherein reassembly of monomeric enzyme fragments is operated by interaction of molecular domains fused to each monomeric enzyme fragment |
| 08/06/2002 | US6428771 Method for drug delivery to the pulmonary system |
| 08/02/2002 | WO2001055207A1 Nucleic acids, proteins, and antibodies |
| 08/02/2002 | CA2395738A1 Nucleic acids, proteins, and antibodies |
| 08/01/2002 | WO2002059609A2 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators |
| 08/01/2002 | WO2002059607A2 Isolation of epidermal stem cells by using the melanoma-associated chondroitin sulfate proteoglycan |
| 08/01/2002 | WO2002059604A2 Diagnosis and treatment of multiple sclerosis |
| 08/01/2002 | WO2002059373A2 Genes overexpressed in prostate disorders as diagnostic and therapeutic targets |
| 08/01/2002 | WO2002059350A2 Use of sialyltransferases for diagnosing and treating tumorous diseases |
| 08/01/2002 | WO2002059346A2 Constitutively active, hypersensitive, and nonfunctional receptors as novel therapeutic agents |
| 08/01/2002 | WO2002059338A2 Retroviral vectors for transduction into quiescent cells and packaging systems for them |
| 08/01/2002 | WO2002059310A2 Polynucleotides encoding cellular transporters and methods of use thereof |
| 08/01/2002 | WO2002059302A2 Regulation of human serotonin-like g protein-coupled receptor |
| 08/01/2002 | WO2002059295A1 Novel serine protease mp493 |
| 08/01/2002 | WO2002059292A2 Functional balanced-lethal host-vector systems |
| 08/01/2002 | WO2002059291A2 Biological organism for preparing pharmaceutical compositions for treating mammals |
| 08/01/2002 | WO2002059270A2 Methods and compositions for expressing polynucleotides specifically in smooth muscle cells in vivo |
| 08/01/2002 | WO2002059261A2 Inhibition of restenosis using a dna-coated stent |
| 08/01/2002 | WO2002059256A2 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
| 08/01/2002 | WO2002059153A2 Anticoagulants and their uses |
| 08/01/2002 | WO2002059138A1 A method for regulating genes with electromagnetic response elements |
| 08/01/2002 | WO2002058728A2 Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses |
| 08/01/2002 | WO2002058724A2 Use of lp82 to treat body weight disorders |
| 08/01/2002 | WO2002058723A2 Chemokines as adjuvants of immune response |
| 08/01/2002 | WO2002058721A1 Trem-1 splice variant for use in modifying immune responses |
| 08/01/2002 | WO2002058718A2 Use of compositions containing pdgf-bb for promoting angiogenesis |
| 08/01/2002 | WO2002058709A1 Methods for inhibiting proliferation of astrocytes and astrocytic tumor cells and uses thereof |
| 08/01/2002 | WO2002058626A2 Methods and compositions for the identification and treatment of neurodegenerative disorders |
| 08/01/2002 | WO2002058450A2 Regulation of cell growth by muc1 |
| 08/01/2002 | WO2002042480A3 Modified vaccinia ankara virus variant |
| 08/01/2002 | WO2002040048A3 Recombined anti-gpiib/iiia antibodies used for inhibiting angiogenesis |
| 08/01/2002 | WO2002036761A9 Compositions and methods for the diagnosis of cancer |
| 08/01/2002 | WO2002030461A3 Methods for treating disorders of the female reproductive system |
| 08/01/2002 | WO2002020614A3 Endoglin-specific polypeptide, production and use thereof |
| 08/01/2002 | WO2002019986A9 Inducing cellular immune responses to hepatitis b virus using peptide and nucleic acid compositions |
| 08/01/2002 | WO2002016620A3 Modulation of stem cell differentiation |
| 08/01/2002 | WO2002008285A3 Il-17 molecules and uses thereof |
| 08/01/2002 | WO2002004509A3 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells |
| 08/01/2002 | WO2002004019A3 Use of strains of the parapox ovis virus against organ fibrosis |
| 08/01/2002 | WO2002002625A3 Novel fibroblast growth factors and nucleic acids encoding same |
| 08/01/2002 | WO2001092551A3 Duplexed parvovirus vectors |
| 08/01/2002 | WO2001091799A3 Medicament for the treatment of immune reactions in the eye |
| 08/01/2002 | WO2001080633A3 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 08/01/2002 | WO2001075114A3 Chlamydia transmembrane protein as antigen, corresponding dna fragments and uses thereof |
| 08/01/2002 | WO2001075113A3 Chlamydia myosin heavy chain homolog as antigen, corresponding dna fragments and uses thereof |
| 08/01/2002 | WO2001074863A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 08/01/2002 | WO2001070979A9 Genes, compositions, kits, and method for identification, assessment, prevention and therapy of ovarian cancer |
| 08/01/2002 | WO2001070955A3 Identification of essential genes in prokaryotes |
| 08/01/2002 | WO2001070950A3 Antisense nucleic acid molecules targeted to type i collagenase (mmp-1) for inhibition of melanoma invasion |
| 08/01/2002 | WO2001062912A3 Method of modulating glycosylation pathways |
| 08/01/2002 | WO2001026672A9 Induction of a strong immune response to a self-tumor associated antigen |
| 08/01/2002 | WO2000077040A9 Human intracellular signaling molecules |
| 08/01/2002 | US20020104108 Expression vector coding polypeptides for use in the treatment of alzheimer's dieases and tumors |
| 08/01/2002 | US20020103353 Sequences characteristic of hypoxia-regulated gene transcription |
| 08/01/2002 | US20020103336 Cloning of chicken anemia dna |
| 08/01/2002 | US20020103156 Administering a nucleic acid to express a gene product in cells by treating the tissue to increase vascular permeability of exogenous nucleic acid; administering exogenous nucleic acid to the tissue; low calcium ion |
| 08/01/2002 | US20020103155 Vectors for the expression of FGF-5 in human cells and uses thereof |
| 08/01/2002 | US20020103151 Methods and compositions for immunomodulation |
| 08/01/2002 | US20020103150 Screening for compounds that affect uncoupling by contacting a cell or tissue sample with a candidate compound and analyzing the expression of human OGC; treating metabolic disorders, e.g. cachexcia; gene therapy |